Group items tagged

Teva UK has begun replacing its existing packaging with a new design which is "clearer and easier to read". The new look is "unique, recognisable and distinctive." It "enhances safety and provides a recognisable and distinguishable pack range." One of the UK's leading generics manufacturers, Teva UK supplies more than 500 generic pharmaceutical products to retail and hospital pharmacies. The company says each product within the portfolio is distinguishable by colour, ensuring no two different packs have the same drug and strength colours and with additional product information on the side of the pack and a simplified back, it makes it even easier to identify the correct product when dispensing and supports patients when taking their medication. "Our medicines impact the lives of millions of people every day and our packaging is often the first touchpoint for our patients and our customers", said Kim Innes, general manager of Teva UK and Ireland.

Morning friends,in today's post I'll try to present a brief review of ACNE PROBLEM IN PREGNANCY. Effect of pregnancy is varied on the presentation of acne.In some women,even the acne may subside during pregnancy.

When someone says erectile dysfunction, the first thing that you may think is of "Viagra" or similar drugs to revive your sex crusade. Even if established medics can assist, they induce side effects, which is why most men choose natural options. Besides, adverse effects of Viagra can result in back pain, memory issues, nausea, loss of hearing, and more. When shifting to natural remedies, you can improve your sexual version without giving the body a ridiculous amount of toxins and chemicals. Ginger, a root vegetable and one of the main ingredients in many traditional Asian dishes, has been used for centuries in conventional medications to treat various ailments. In recent years, ginger has received attention as an herbal remedy for sexual health problems such as erectile dysfunction (ED), premature ejaculation (PE), and infertility. It turns out that this ancient herb can be very effective at improving your sex life! How Does Ginger Benefits Male Sexually? Its potent medicinal combinations have made this natural treatment a focal point in investigations and comprehensive research over the years. Here is what makes ginger (zingiber officinale) a mighty sexual therapy. We've enclosed all the benefits it can suggest. But, nothing has gained more momentum than its impact on male sexual ability. 1. Ginger is an aphrodisiac and boosts sex drive. Ginger has been used as an aphrodisiac for centuries. An aphrodisiac is any food or medicine that stimulates sexual intuition, cajoles veneral craving, and boosts pleasure and performance. The spicy flavor of ginger can help increase your libido and has also been shown to improve erectile dysfunction and sexual performance in men. Aside from its role as an aphrodisiac, ginger is also a known sperm motility enhancer. In fact, according to clinical studies, just one gram of fresh ginger can improve sperm count by up to 35 percent! 2. It can improve sexual satisfaction. Ginger can also improve overall sexual satisfaction by

Department of Health and Social Care (DHSC) has issued a medicine supply notification for GLP-1 receptor agonists used in the management of type 2 diabetes on Tuesday (27 June). "There are very limited, intermittent supplies of all glucagon-like peptide-1 receptor agonists (GLP-1 RAs) licensed in the management of Type 2 Diabetes Mellitus (T2DM)," said DHSC. The supply issues have been caused by an increase in demand for these products for licensed and off-label indications and it is not expected to return to normal until at least mid-2024. Pharmacists are urged to refer to the SPS Tool for Medicines Shortages for an up-to-date supply stock situation and clinical guidance on alternative treatment options.

Consumer healthcare group Haleon on Thursday announced that it has entered into a binding agreement for the sale of the ChapStick brand to Suave Brands Company, a company owned by American private equity firm Yellow Wood Partners. The British consumer healthcare company has agreed to sell its lip balm brand to Suave for about $430 million in cash and a minority interest in the buyer, valued at around $80 million. Haleon, which was spun off from the GSK Group in July 2022, said that cash proceeds from the sale would be used to pay down debt. ChapStick generated £112 million ($142.5 million) in revenue in 2023, said Haleon, adding that the sale is likely to close in the second quarter of 2024. Brian McNamara, Chief Executive Officer, Haleon, said: "Today's announcement is consistent with Haleon being proactive in managing our portfolio, and being rigorous and disciplined where there are opportunities for divestment. "While ChapStick is a great brand, much loved by consumers around the world, it is not a core focus for Haleon.

The UK government on Wednesday (7 February) announced a new plan to ensure faster, simpler and fairer access to NHS dental care across England. Supported by £200m of funding, the plan aims to deliver more than 1.5 million additional NHS dentistry treatments or up to 2.5 million NHS dental appointments for patients over the next 12 months NHS dentists will be offered a 'new patient' payment of between £15-£50, depending on treatment need, to treat new patients who have not seen a dentist in two years or more. Additionally, one-off payments of up to £20,000 will be given to around 240 dentists for working in under-served areas for up to three years. This is to "attract new NHS dentists and improve access to dental care in areas with the highest demand," NHS England said in a statement released on Wednesday.

Adding to the growing evidence of global medicine shortages, a new study has revealed that the European generic medicines market is "not in shape" to help Europe meet its public health priorities. In the past decade, the rate of generic medicines withdrawals has risen by 12 per cent, while there has been a three per cent decrease in the launch of generic products, as per Teva Pharmaceuticals' recent analysis of IQVIA data. Within the mental therapeutic area, seven per cent of generic products disappeared between 2013 and 2023, while there was a seven per cent decrease in the availability of generic cancer medicines in just six years (2017-2022). These medicines were listed on the Union List of Critical Medicines to help avoid potential shortages, as the European Commission (EC) said this could cause "significant harm to patients and pose important challenges to health systems." While mature generic products constitute the majority of the List, they remain susceptible to withdrawals, despite containing products crucial for safeguarding Europe's public health, the Teva analysis report noted. Since 2013, the number of generic products for the treatment of schizophrenia and bipolar disorder has declined by 25 per cent, with Hungary and Bulgaria experiencing the biggest loss at 83 per cent and 58 per cent respectively.